D. Togasaki

发表

Effects of Treadmill Exercise on Dopaminergic Transmission in the 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Lesioned Mouse Model of Basal Ganglia Injury

John P. Walsh, Daniel M. Togasaki, G. Akopian, 2007, The Journal of Neuroscience.

Inosine to increase serum and cerebrospinal fluid urate in Parkinson disease: a randomized clinical trial.

J. Friedman, J. Carter, M. Beal, 2014, JAMA neurology.

Levodopa induces dyskinesias in normal squirrel monkeys

J. Langston, D. D. Di Monte, D. Togasaki, 2001, Annals of neurology.

Dyskinesias in normal squirrel monkeys induced by nomifensine and levodopa

J. Langston, D. Togasaki, L. Tan, 2005, Neuropharmacology.

Long‐term safety and efficacy of preladenant in subjects with fluctuating Parkinson's disease

M. Cantillon, S. Factor, R. Hauser, 2013, Movement disorders : official journal of the Movement Disorder Society.

Effects of Wild‐Type and Mutated Copper/Zinc Superoxide Dismutase on Neuronal Survival and l‐DOPA‐Induced Toxicity in Postnatal Midbrain Culture

C. Epstein, D. Sulzer, D. Togasaki, 1997, Journal of neurochemistry.

J. Langston, D. D. Di Monte, D. Togasaki, 2002 .

CD4 cell response to interval therapy with natalizumab

L. Steinman, D. Togasaki, S. Cen, 2015, Annals of clinical and translational neurology.

Dextromethorphan/Quinidine in Migraine Prophylaxis: An Open-label Observational Clinical Study

D. Togasaki, R. Berkovich, A. Sokolov, 2018, Clinical neuropharmacology.

L-dihydroxyphenylalanine-induced asymmetric changes in striatal uric acid peak: determination by in vivo electrochemical detection in rats with unilateral nigrostriatal lesions.

D. Togasaki, J. G. Young, P. Knott, 1987, Life sciences.

Dose-dependent lesions of the dopaminergic nigrostriatal pathway induced by instrastriatal injection of 6-hydroxydopamine

D. Togasaki, D. Donaldson, V. Jackson-Lewis, 1995, Neuroscience.

The selective κ-opioid receptor agonist U50,488 reduces l-dopa-induced dyskinesias but worsens parkinsonism in MPTP-treated primates

J. Langston, Li Chen, D. Togasaki, 2007, Experimental Neurology.

Caffeine consumption and risk of dyskinesia in CALM‐PD

C. Tanner, D. Togasaki, M. Schwarzschild, 2013, Movement disorders : official journal of the Movement Disorder Society.

unilateral strokes Direct evidence of acute, massive striatal dopamine release in gerbils with

J. Weinberger, D. Togasaki, H. Kaufmann, 2011 .

Direct Evidence of Acute, Massive Striatal Dopamine Release in Gerbils with Unilateral Strokes

J. Weinberger, D. Togasaki, H. Kaufmann, 1987, Stroke.

Memory, mood, dopamine, and serotonin in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mouse model of basal ganglia injury

R. Wood, G. Petzinger, M. Jakowec, 2008, Neurobiology of Disease.

Imaging and therapeutics: the role of neuronal transport in the regional specificity of L-DOPA accumulation in brain.

J. Langston, J. Barrio, N. Satyamurthy, 2002, Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging.

The Webcam system: a simple, automated, computer-based video system for quantitative measurement of movement in nonhuman primates

Daniel M. Togasaki, Albert Hsu, Meghana Samant, 2005, Journal of Neuroscience Methods.

Neuroleptics Up‐Regulate Adenosine A2a Receptors in Rat Striatum: Implications for the Mechanism and the Treatment of Tardive Dyskinesia

B. Parsons, D. Togasaki, S. Przedborski, 1995, Journal of neurochemistry.

Caffeine stimulates β-endorphin release in blood but not in cerebrospinal fluid

Daniel M. Togasaki, Joseph B. Martin, D. Togasaki, 1982 .

Enhanced striatal opioid receptor-mediated G-protein activation in l-dopa-treated dyskinetic monkeys

J. Langston, L. Chen, Li Chen, 2005, Neuroscience.

Novel observations with FDOPA‐PET imaging after early nigrostriatal damage

J. Langston, S-C. Huang, N. Satyamurthy, 2001, Movement disorders : official journal of the Movement Disorder Society.

Computer-Based Motor Training Activities Improve Function in Parkinson ’ s Disease : a Pilot Study

D. Togasaki, 2005 .

Non-human Primate Models of Parkinson's Disease and Experimental Therapeutics

G. Akopian, J. Walsh, G. Petzinger, 2008 .

Quantitative assessment of quinolinic acid-induced striatal toxicity in rats using radioligand binding assays.

J. Brotchi, M. Levivier, D. Togasaki, 1994, Neurological research.

Systemic and intrastriatal theophylline have opposite effects on dopamine and dopamine metabolites measured by intrastriatal microdialysis in the rat

P. Damhaut, J. Hildebrand, D. Togasaki, 1996, Neuroscience Letters.

Effect of the D3 Dopamine Receptor Partial Agonist BP897 [N-[4-(4-(2-Methoxyphenyl)piperazinyl)butyl]-2-naphthamide] on l-3,4-Dihydroxyphenylalanine-Induced Dyskinesias and Parkinsonism in Squirrel Monkeys

E. Bézard, P. Sokoloff, J. Langston, 2004, Journal of Pharmacology and Experimental Therapeutics.

Effect of Urate-Elevating Inosine on Early Parkinson Disease Progression: The SURE-PD3 Randomized Clinical Trial.

D. Mozaffarian, Z. Mari, H. Shill, 2021, JAMA.

The hyperkinetic abnormal movements scale: A tool for measuring levodopa‐induced abnormal movements in squirrel monkeys

D. Togasaki, J. Langston, Louis C. Tan, 2002, Movement disorders : official journal of the Movement Disorder Society.

Effect of the D 3 Dopamine Receptor Partial Agonist BP 897 on L-Dopa-Induced Dyskinesias and Parkinsonism in Squirrel Monkeys *

E. Bézard, P. Sokoloff, D. Togasaki, 2004 .